Russia's vaccine can help Latin America, but faces obstacles

Now that prominent s.British peer-reviewed medical journal The Lancet has reported that recent trials of  the Gamaleya-developed "Sputnik V" Covid vaccine shows no adverse affects and generates antibody response, Kremlin supported efforts to produce and further test the vaccine and make it available worldwide later this year could help mediate the public health crisis in Latin America, which, with the United States and  India ranks as one of the three major Covid hotspots. In the Arab world...